255 related articles for article (PubMed ID: 29958990)
1. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
[TBL] [Abstract][Full Text] [Related]
2. Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation.
Tessarolo Silva F; Pedreira GC; Medeiros SA; Bortolotto AL; Araujo Silva B; Hurrey M; Madhavapeddi P; Schuler C; Belardinelli L; Verrier RL
J Cardiovasc Electrophysiol; 2020 Jan; 31(1):205-213. PubMed ID: 31749267
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary delivery of flecainide causes a rate-dependent predominant effect on atrial compared with ventricular depolarization duration revealed by intracardiac recordings in an intact porcine model.
de Antonio VZ; Silva AC; Stocco FG; Silva BA; Marum AA; Bortolotto AL; Belardinelli L; Verrier RL
J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1563-1569. PubMed ID: 30106207
[TBL] [Abstract][Full Text] [Related]
4. Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration.
Marum AA; Silva BA; Bortolotto AL; Silva AC; de Antonio VZ; Belardinelli L; Verrier RL
Int J Cardiol; 2019 Jan; 274():170-174. PubMed ID: 30217428
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Delivery of Metoprolol Reduces Ventricular Rate During Atrial Fibrillation and Accelerates Conversion to Sinus Rhythm.
Marum AA; Araujo Silva B; Bortolotto AL; Pedreira GC; Tessarolo Silva F; Medeiros SA; Nearing BD; Belardinelli L; Verrier RL
J Cardiovasc Pharmacol; 2020 Feb; 75(2):135-140. PubMed ID: 31789885
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation.
Verrier RL; Belardinelli L
J Cardiovasc Pharmacol; 2020 Apr; 75(4):276-283. PubMed ID: 32032206
[TBL] [Abstract][Full Text] [Related]
7. Flecainide-induced QRS complex widening correlates with negative inotropy.
Rabêlo Evangelista AB; Monteiro FR; Nearing BD; Belardinelli L; Verrier RL
Heart Rhythm; 2021 Aug; 18(8):1416-1422. PubMed ID: 33848647
[TBL] [Abstract][Full Text] [Related]
8. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
[TBL] [Abstract][Full Text] [Related]
9. Comparative Pharmacokinetic and Electrocardiographic Effects of Intratracheal and Intravenous Administration of Flecainide in Anesthetized Pigs.
Stocco FG; Evaristo E; Silva AC; de Antonio VZ; Pfeiffer J; Rangachari N; Belardinelli L; Verrier RL
J Cardiovasc Pharmacol; 2018 Sep; 72(3):129-135. PubMed ID: 29923887
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Martínez-Marcos FJ; García-Garmendia JL; Ortega-Carpio A; Fernández-Gómez JM; Santos JM; Camacho C
Am J Cardiol; 2000 Nov; 86(9):950-3. PubMed ID: 11053705
[TBL] [Abstract][Full Text] [Related]
11. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
[TBL] [Abstract][Full Text] [Related]
12. Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation.
Ohmura H; Nukada T; Mizuno Y; Yamaya Y; Nakayama T; Amada A
J Vet Med Sci; 2000 Jul; 62(7):711-5. PubMed ID: 10945288
[TBL] [Abstract][Full Text] [Related]
13. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
[TBL] [Abstract][Full Text] [Related]
14. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Frommeyer G; Sterneberg M; Dechering DG; Kaese S; Bögeholz N; Pott C; Fehr M; Bogossian H; Milberg P; Eckardt L
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
[TBL] [Abstract][Full Text] [Related]
15. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation.
van Loon G; Blissitt KJ; Keen JA; Young LE
Equine Vet J; 2004 Nov; 36(7):609-14. PubMed ID: 15581326
[TBL] [Abstract][Full Text] [Related]
17. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Suttorp MJ; Kingma JH; Lie-A-Huen L; Mast EG
Am J Cardiol; 1989 Mar; 63(11):693-6. PubMed ID: 2493733
[TBL] [Abstract][Full Text] [Related]
18. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.
Hesselkilde EZ; Carstensen H; Haugaard MM; Carlson J; Pehrson S; Jespersen T; Buhl R; Platonov PG
BMC Cardiovasc Disord; 2017 Dec; 17(1):289. PubMed ID: 29221440
[TBL] [Abstract][Full Text] [Related]
19. Restoration of sinus rhythm with flecainide in patients with atrial fibrillation.
Goy JJ; Kaufmann U; Kappenberger L; Sigwart U
Am J Cardiol; 1988 Aug; 62(6):38D-40D. PubMed ID: 3136634
[TBL] [Abstract][Full Text] [Related]
20. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
